Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis

KEY CLINICAL MESSAGE: Malignancies were reported in some studies following taking Fingolimod. We reported a case of bladder lymphoma after taking Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long‐term use and replace it with safer medicines. ABSTRACT: Fingolimod i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaheb, Saeed, Ghaffary, Elham Moases, Shaygannejad, Vahid, Mirmosayyeb, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126755/
https://www.ncbi.nlm.nih.gov/pubmed/37113637
http://dx.doi.org/10.1002/ccr3.7280
_version_ 1785030327227383808
author Vaheb, Saeed
Ghaffary, Elham Moases
Shaygannejad, Vahid
Mirmosayyeb, Omid
author_facet Vaheb, Saeed
Ghaffary, Elham Moases
Shaygannejad, Vahid
Mirmosayyeb, Omid
author_sort Vaheb, Saeed
collection PubMed
description KEY CLINICAL MESSAGE: Malignancies were reported in some studies following taking Fingolimod. We reported a case of bladder lymphoma after taking Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long‐term use and replace it with safer medicines. ABSTRACT: Fingolimod is a medication with a potential cure to control multiple sclerosis (MS) relapses. Here we describe a 32‐year‐old woman with relapsing–remitting multiple sclerosis who developed bladder lymphoma induced by long‐term use of Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long‐term use and replace it with safer medicines.
format Online
Article
Text
id pubmed-10126755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101267552023-04-26 Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis Vaheb, Saeed Ghaffary, Elham Moases Shaygannejad, Vahid Mirmosayyeb, Omid Clin Case Rep Case Report KEY CLINICAL MESSAGE: Malignancies were reported in some studies following taking Fingolimod. We reported a case of bladder lymphoma after taking Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long‐term use and replace it with safer medicines. ABSTRACT: Fingolimod is a medication with a potential cure to control multiple sclerosis (MS) relapses. Here we describe a 32‐year‐old woman with relapsing–remitting multiple sclerosis who developed bladder lymphoma induced by long‐term use of Fingolimod. Physicians should consider the carcinogenic effects of Fingolimod in long‐term use and replace it with safer medicines. John Wiley and Sons Inc. 2023-04-24 /pmc/articles/PMC10126755/ /pubmed/37113637 http://dx.doi.org/10.1002/ccr3.7280 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Vaheb, Saeed
Ghaffary, Elham Moases
Shaygannejad, Vahid
Mirmosayyeb, Omid
Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title_full Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title_fullStr Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title_full_unstemmed Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title_short Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
title_sort fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126755/
https://www.ncbi.nlm.nih.gov/pubmed/37113637
http://dx.doi.org/10.1002/ccr3.7280
work_keys_str_mv AT vahebsaeed fingolimodinducedbladderlymphomainapatientwithmultiplesclerosis
AT ghaffaryelhammoases fingolimodinducedbladderlymphomainapatientwithmultiplesclerosis
AT shaygannejadvahid fingolimodinducedbladderlymphomainapatientwithmultiplesclerosis
AT mirmosayyebomid fingolimodinducedbladderlymphomainapatientwithmultiplesclerosis

Ejemplares similares